First Time Loading...

Beijing Strong Biotechnologies Inc
SZSE:300406

Watchlist Manager
Beijing Strong Biotechnologies Inc Logo
Beijing Strong Biotechnologies Inc
SZSE:300406
Watchlist
Price: 18.49 CNY 4.17% Market Closed
Updated: Apr 29, 2024

Relative Value

The Relative Value of one Beijing Strong Biotechnologies Inc stock under the Base Case scenario is 26.66 CNY. Compared to the current market price of 18.49 CNY, Beijing Strong Biotechnologies Inc is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
26.66 CNY
Undervaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
93
vs Industry
60
Median 3Y
6.9
Median 5Y
8.2
Industry
8.1
Forward
5.2
vs History
95
vs Industry
8
Median 3Y
28
Median 5Y
28
Industry
26.2
Forward
17.4
vs History
96
vs Industry
9
Median 3Y
27.4
Median 5Y
32.1
Industry
22.6
vs History
61
vs Industry
6
Median 3Y
21.9
Median 5Y
28.4
Industry
21.3
vs History
90
vs Industry
33
Median 3Y
3.3
Median 5Y
3.6
Industry
2.5
vs History
93
vs Industry
48
Median 3Y
7.4
Median 5Y
7.9
Industry
7.3
Forward
5.4
vs History
95
vs Industry
44
Median 3Y
10
Median 5Y
11.6
Industry
9.1
vs History
93
vs Industry
7
Median 3Y
21.4
Median 5Y
22.3
Industry
4.4
vs History
93
vs Industry
7
Median 3Y
21.4
Median 5Y
22.3
Industry
4.3
vs History
96
vs Industry
8
Median 3Y
28.6
Median 5Y
32.6
Industry
5.4
vs History
96
vs Industry
6
Median 3Y
38.1
Median 5Y
42.1
Industry
3.2
vs History
88
vs Industry
44
Median 3Y
2.8
Median 5Y
3.1
Industry
5

Multiples Across Competitors

Competitors Multiples
Beijing Strong Biotechnologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing Strong Biotechnologies Inc
SZSE:300406
10.9B CNY 6.2 20.8 18 18
US
Abbvie Inc
NYSE:ABBV
281.9B USD 5.2 58.5 12.7 19.4
US
Amgen Inc
NASDAQ:AMGN
146.2B USD 5.2 21.8 16.2 24.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102B USD 10.3 28.2 22.5 23.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
97.7B USD 7.5 24.7 16.3 18
AU
CSL Ltd
ASX:CSL
132.9B AUD 6.1 35.1 21.3 26.4
US
Gilead Sciences Inc
NASDAQ:GILD
82.9B USD 3.1 14.6 8 10.3
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
42.4B USD 6.2 -9 -9.5 -8.1
US
Biogen Inc
NASDAQ:BIIB
31.6B USD 3.2 27.2 14.7 18.2
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD 7.3 60.8 27.9 47

See Also

Discover More